Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
26.93
+1.84 (7.33%)
At close: Feb 19, 2026, 4:00 PM EST
27.00
+0.07 (0.26%)
After-hours: Feb 19, 2026, 4:43 PM EST
Surrozen Market Cap
Surrozen has a market cap or net worth of $230.83 million as of February 19, 2026. Its market cap has increased by 551.04% in one year.
Market Cap
230.83M
Enterprise Value
156.58M
1-Year Change
551.04%
Ranking
Category
Stock Price
$26.93
Market Cap Chart
Since January 11, 2021, Surrozen's market cap has increased from $120.65M to $230.83M, an increase of 91.32%. That is a compound annual growth rate of 13.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 215.06M | 11.02% |
| Dec 31, 2025 | 193.71M | 315.39% |
| Dec 31, 2024 | 46.63M | 143.39% |
| Dec 29, 2023 | 19.16M | 10.72% |
| Dec 30, 2022 | 17.31M | -92.33% |
| Dec 31, 2021 | 225.58M | 86.96% |
| Jan 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sol-Gel Technologies | 227.74M |
| Orchestra BioMed Holdings | 225.86M |
| Achieve Life Sciences | 223.05M |
| Heron Therapeutics | 221.87M |
| MediWound | 219.63M |
| Alector | 216.67M |
| Arcturus Therapeutics Holdings | 213.39M |
| Context Therapeutics | 213.16M |